Article L5222-3 of the French Public Health Code
The obligations of notification to the National Agency for the Safety of Medicines and Health Products or of information incumbent, under the vigilance exercised over the devices mentioned in Article 1 of Regulation (EU) 2017/746, on the manufacturer or, where applicable, his authorised representative, the importer and the distributor, are defined by this Regulation, in particular in Articles 10, 13, 14, 82, 83 and 84. In addition, any healthcare professional…